FormWeb • pomalidomide

IHS FormWeb

Approved Formulary

Search by class Show Therapeutic Classes

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

IHS FormWeb

Approved Formulary

REMS FDA Documents #1^FDA Documents #2

Search results for:

pomalidomide

pomalidomide

Restricted Medications Non-Formulary / Non-Stocked
REMS FDA Documents #1
REMS FDA Documents #2

Brand names: Pomalyst

No brands, forms, or strengths have been added for this generic.

Display Antineoplastic Agents, Immunomodulatory Agents Class: 100000, 922000

High Alert Drug : Policy

Medication comments:

High Alert Drug: Chemotherapeutic Agents - Oral
• Stored separately in pharmacy. • Drugs are transported in plastic bags/designated transport containers labeled with sticker indicating CHEMOTHERAPY DRUG.

Per policy, these hazardous drugs have special waste requirements.
Generic (Brand)	Waste Requirements
pomalidomide (Pomalyst)	If > 3% by weight of drug remains ⇒ BLACK BUCKET Trace amounts/uncontaminated PPE ⇒ YELLOW BUCKET

USP <800> Hazardous Drugs
Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances).
generic (Brand) Route	Relative Risk Level	AOR?	NIOSH 2024 Table	MSHI?^↑	Warnings
pomalidomide (Pomalyst) PO	High	N/A	1^↑	Yes
NIOSH Supplemental information (2016): Females of reproductive potential must use two forms of contraception or continuously abstain from heterosexual sex during and for 4 weeks after stopping treatment FDA Pregancy Category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits;

Last updated: Jun. 11, 2025

Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug
Hazardous Waste BLACK BUCKET/YELLOW BUCKET
Chemotherapy Chemotherapy
Black Box Warnings Embryo-Fetal Toxicity And Venous And Arterial Thromboembolism

UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.